Form 4: Arteris COO Sells Minor Stake Under Pre-Arranged 10b5-1 Trading Plan

Arteris, Inc.'s Chief Operating Officer, Laurent R. Moll, sold 202 shares of common stock for $7.96 per share on June 4, 2025, as part of a pre-arranged 10b5-1 trading plan.

Summary

• Laurent R. Moll, the Chief Operating Officer of Arteris, Inc. (AIP), reported a transaction on June 4, 2025.
• The transaction involved the sale of 202 shares of Arteris common stock.
• The shares were sold at a price of $7.96 per share.
• Following this transaction, Mr. Moll beneficially owns 483,759 shares of Arteris common stock.
• The sale was executed pursuant to a Rule 10b5-1 trading plan, which was adopted by Mr. Moll on March 15, 2024.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While it's an insider sale, the fact that it was conducted under a pre-arranged 10b5-1 plan reduces any negative implications, suggesting a planned liquidity event rather than a reaction to new negative information.

Positives

• The transaction was conducted under a Rule 10b5-1 trading plan, indicating a pre-scheduled and non-discretionary sale, which can mitigate negative market interpretations often associated with insider sales.

Negatives

• An insider sale, even if pre-planned, can sometimes be perceived by the market as a lack of confidence, although the small volume in this instance lessens this impact.

Future Outlook

The document, being an insider transaction report (Form 4), does not provide any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This Form 4 filing details a routine insider transaction for Arteris, Inc.'s Chief Operating Officer. Such filings are standard disclosures and do not typically reflect broader industry trends or competitive dynamics, but rather individual executive compensation or liquidity management strategies.

Stakeholder Impact

• Shareholders: The sale of 202 shares is a very small volume relative to the company's total outstanding shares and is unlikely to have a material impact on the share price or overall shareholder value. The 10b5-1 plan context provides transparency.

Key Dates

Keywords

Arteris, AIP, SEC Form 4, Insider Trading, 10b5-1 Plan, Common Stock, Share Sale, Laurent R. Moll, Chief Operating Officer